Inventor · disambiguated record
Seok Jong Kang
Also filed as: KANG SEOK JONG
9 granted patents·1 pending application·39 citations·filing 2011–2022
85Inventor score
Top patents by PatentIndex Score
10 records- 0193US11292786B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2020·Granted Apr 5, 2022·4 cites·7 claims
- 0288US8957065B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityCHA MI YOUNG·Filed 2011·Granted Feb 17, 2015·20 cites·27 claims
- 0387US10280154B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 7, 2019·4 cites·18 claims
- 0485US10519141B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 31, 2019·3 cites·11 claims
- 0584US10870639B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2019·Granted Dec 22, 2020·3 cites·6 claims
- 0681US9345719B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2014·Granted May 24, 2016·4 cites·31 claims
- 0776US12325698B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARMACEUTICAL CO LTD·Filed 2022·Granted Jun 10, 2025·0 cites·8 claims
- 0869USRE46511EFused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2011·Granted Aug 15, 2017·1 cites·54 claims
- 0952US2016229868A1Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2016·Application pending·0 cites
- 1048US10781217B2Imidazopyridazine compoundHANMI PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 22, 2020·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Seok Jong Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →